A Treatment for Parkinson’s That Does Not Involve the Use of Embryonic Cells

August 07, 2018
By fsspx.news
news-header-image

A research team at the University of Kyoto has announced that on August 1, 2018, they injected millions of iPS cells into the brains of seven patients aged 50 to 69, all with Parkinson’s disease.

This clinical experiment is important for two reasons; first of all, it offers the hope of stopping this neurodegenerative disease that destroys a certain type of neurons, causing slowness in movements, muscular rigidity, and trembling. Over ten million people throughout the world are currently suffering from this disease.

The other reason that makes this scientific breakthrough important is the choice of iPS cells. Many experiments use embryonic stem cells that come from embryos (and therefore human beings) taken from an in vitro fertilization and destroyed during the experiment; this practice consists quite simply in eliminating a human person, no more, no less.

iPS cells, however – pluripotent stem cells or induced pluripotent cells – offer an alternative. They do not involve taking cells from a human embryo that will be eliminated; instead they are adult cells that are brought back to the pluripotent state, that is, to a state in which they are sufficiently undifferentiated to be able to regenerate all the cells of an organism after multiplying and being specialized.

In the case of the clinical test conducted on August 1, the cells were taken from healthy donors and not from the patients. The researchers hope that they will differentiate into neurons to replace those destroyed by the disease. They will be under observation for the next two years.

The hope of finding a cure is important, for it is a recognized fact that the use of iPS cells, which is morally acceptable, is more effective… but also more expensive. But is respect for God’s rights over every human creature not of a priceless value?

Sources: La Croix / FSSPX.News